Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 4, 2021
Bio-vehicles of cytotoxic drugs for delivery to tumor specific targets for cancer precision therapyLayla Al-Mansoori, Philip Elsinga, Sayed K Goda
Current Pharmaceutical Design|August 30, 2016
PET Tracers for Imaging of ABC Transporters at the Blood-Brain Barrier: Principles and StrategiesGert Luurtsema, Philip Elsinga, Rudi Dierckx, et al.
Technology in Cancer Research & Treatment|November 22, 2021
Production of Long-Acting CNGRC-CPG2 Fusion Proteins: New Derivatives to Overcome Drug Immunogenicity of Ligand-Directed Enzyme Prodrug Therapy for Targeted Cancer TreatmentLayla Al-Mansoori, Alanod D Al Qahtani, Philip Elsinga, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 11, 2012
Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implicationsJan-Peter van Wieringen, Jan Booij, Vladimir Shalgunov, et al.
EJNMMI Radiopharmacy and Chemistry|October 10, 2021
EANM guideline for harmonisation on molar activity or specific activity of radiopharmaceuticals: impact on safety and imaging qualityGert Luurtsema, Verena Pichler, Salvatore Bongarzone, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 16, 2014
Imaging the folate receptor on cancer cells with 99mTc-etarfolatide: properties, clinical use, and future potential of folate receptor imagingAlan H Maurer, Philip Elsinga, Stefano Fanti, et al.
Annals of Nuclear Medicine|September 26, 2021
Test-retest reproducibility of cerebral adenosine A2A receptor quantification using [11C]preladenantJun Toyohara, Muneyuki Sakata, Kei Wagatsuma, et al.
Drug Discovery Today|September 17, 2025
Harnessing zebrafish as a model for photopharmacology: Insights into light-controlled biological effects of photoswitchable drugsGuilherme Pietro da Silva, Janine Doorduin, Wiktor Szymanski, et al.
Oncotarget|February 29, 2020
In vitro studies on CNGRC-CPG2 fusion proteins for ligand-directed enzyme prodrug therapy for targeted cancer therapyLayla Al-Mansoori, Sara S Bashraheel, Alanod D Al Qahtani, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 22, 2018
Production of "biobetter" glucarpidase variants to improve drug detoxification and antibody directed enzyme prodrug therapy for cancer treatmentAlanod D AlQahtani, Layla Al-Mansoori, Sara S Bashraheel, et al.
Pageof 2